Drug intelligence / Profile preview

Jiebiaoqingli

Development stage: Unknown
Lead developer: China-Japan Friendship Hospital
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Jiebiaoqingli (also known as Jiebiaoqingli Recipe or Formula) is a Traditional Chinese Medicine (TCM) herbal preparation developed by the China-Japan Friendship Hospital. It is specifically formulated to treat respiratory virus infections, such as influenza, characterized by the "exterior cold and interior heat" syndrome. This syndrome typically involves symptoms like fever, chills, and cough. The formula is used within an integrated Traditional Chinese and Western medicine framework to improve clinical outcomes and safety in patients with viral respiratory tract infections.

Other names: Jiebiaoqingli RecipeJiebiaoqingli Formula解表清里方

Beyond the preview

Go deeper on Jiebiaoqingli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiebiaoqingli.

Explore the full profile